Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: The Dodgy Ticker who wrote (289)	12/28/1999 5:18:00 PM
From: RWReeves	Respond to of 743

Thanks Bob for popping in. I will gladly take a look at ANTX. My investment criteria are obviously different from Rick's for the LTAB issues. Many of these issues have some impairment, real or imagined, that brings them to the bargain basement. Still some have decent science or business plans and can make their way into back the sunlight. For example, IMMU today became a 90 day 10-bagger on the original position and there are some fine recoveries underway with many many excellent gains. I have to say I doubted IMMU's conversion from diagnostics to therapeutics but Mr. Market liked it and continues to bid it up. While I like "special situations" which are often found in LTAB, I do more lean to the value plays espoused here on SI in general but we can't dictate to the market what it is going to like. So I chase a few momentum plays as well, a bad habit I've picked up this year. Would invite you and others to post pros/cons on the thread as you like. I value diverse opinions, something I learned from 20 years of product and corporate development in Biotech and Devices. RWR